Back to search results
NCT06457256

Hybrid Effectiveness-Implementation Trial of a School Clinician Training and Psychosocial ADHD/ODD Intervention Program Adapted for Schools Across Mexico

Enrolling by Invitation
NAAges 5+InterventionalHealth services
University of California, San Francisco
~872 participants
Updated 2025-08-21 on ClinicalTrials.gov
What's tested:CLS-A-FUERTE

At a glance

Recruiting sites
0 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in Child Symptom Inventory-4 (CSI-4) Parent Checklist ADHD Combined type Symptom Severity Score
Measured over Baseline and post treatment (8 weeks) and follow-up (3 months)
+1 more outcome measured

Conditions

ADHD

Explore related trials

Attention Deficit Hyperactivity DisorderOppositional Defiant Disorder

Where it's being run

3 sites across 3 states
California1
Puebla1
Sinaloa1

Study leadership

  • Lauren Haack, PhD · PRINCIPAL_INVESTIGATOR · University of California, San Francisco

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

must demonstrate at least six inattention symptoms and/or six hyperactive/impulsive symptoms endorsed by parent or teacher as occurring often or very often, AND at least one area of impairment rated as concerning by both parent and teacher, AND have a parent and teacher agreeing to participate (for student participants)
Must be a parents, teacher, or school clinicians of participating students (for parent, teacher, and school clinician participants)
Must be a university student in psychology or education at UAS or BUAP (for emerging investigator/university student participants)

Exclusion

inability to speak and read Spanish
unstable medication regimen (for student participants)
severe visual or hearing impairment (for student participants)
severe language delay (for student participants)
psychosis (for student participants)
Placement in an all-day special education classroom (for student participants)

What this trial measures

  • Change in Child Symptom Inventory-4 (CSI-4) Parent Checklist ADHD Combined type Symptom Severity ScoreBaseline and post treatment (8 weeks) and follow-up (3 months)

    Parents will assess ADHD symptoms using the CSI-4. The CSI-4: Parent Checklist contains 18 symptoms for ADHD, Combined type (ADHD:C; 18 items). Each symptom is rated on a 4-point scale (0= never to 3= very often). The average of ADHD:C scores range from zero to four, with higher scores indicating more severe symptoms.

  • Change in Child Symptom Inventory-4 (CSI-4) Teacher Checklist ADHD Combined type Symptom Severity ScoreBaseline and post treatment (8 weeks) and follow-up (3 months)

    Teachers will assess ADHD symptoms using the CSI-4. The CSI-4: Teacher Checklist contains 18 symptoms for ADHD, Combined type (ADHD:C; 18 items). Each symptom is rated on a 4-point scale (0= never to 3= very often). The average of ADHD:C scores range from zero to four, with higher scores indicating more severe symptoms.